This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Omic Smap Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nayeon Kim: Innovator in Cancer Treatment
Introduction
Nayeon Kim is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. His innovative work has garnered attention for its potential impact on cancer therapies.
Latest Patents
Nayeon Kim holds a patent for a Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer. This compound exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2). The invention highlights the compound's potential as an active ingredient in cancer treatment, showcasing its effectiveness in combating this devastating disease.
Career Highlights
Nayeon Kim is associated with Omic Smap Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on creating effective solutions for cancer treatment.
Collaborations
Some of his notable coworkers include Jung Jin Hwang and Sang Eun Park. Their collaborative efforts contribute to the ongoing research and development initiatives at Omic Smap Inc.
Conclusion
Nayeon Kim's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving healthcare outcomes. His work exemplifies the importance of research and innovation in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile